1:45pm Lunchtime Symposium Salon FK Title: Combination

Monday, November 7th
12:45pm – 1:45pm
Lunchtime Symposium
Salon F-K
Title: Combination Strategies in Melanoma Management: What’s New and What’s
Next?
12:45pm – 12:55pm
Introduction and Pre-Test
Antoni Ribas, MD
12:55pm – 1:20pm
New and Emerging Concepts in Melanoma Management:
Focus on Combination Treatment
Caroline Robert, MD
1:20pm – 1:30pm
Case Presentation
Antoni Ribas, MD
1:30pm – 1:45pm
Post-test and Q&A
Moderated by Antoni Ribas, MD
This continuing medical education activity is provided by Vindico Medical Education
This activity is supported by an educational grant from Genentech, Inc.
Monday, November 7th
12:45pm – 1:45pm
Lunchtime Symposium
Salon E
Title: Checkpoint Inhibition for Melanoma Management: When, What, How, and in
Whom?
12:45pm – 12:55pm
Introduction and Pre-test
John M. Kirkwood, MD
12:55pm – 1:20pm
Immune Checkpoint Inhibition in Melanoma
Management: Sequencing and Combination Approaches
Ahmad A. Tarhini, MD, PhD
1:20pm – 1:30pm
Case Presentation: Content to be guided by faculty and is
designed to supplement the material discussed in the
proceeding didactic presentation.
John M. Kirkwood, MD
1:30pm – 1:45pm
Post-test and Q&A
Time
Topic John M. Kirkwood, MD
This continuing medical education activity is provided by Vindico Medical Education
This activity is supported by educational grants from Bristol-Myers Squibb and Merck &
Co., Inc.
Tuesday, November 8th
12:45pm – 1:45pm
Lunchtime Symposium
Salon F-K
Title: Toward Precision Medicine for Advanced Melanoma Management: Making
the Most of Targeted Agents
12:45pm – 12:55pm
Introduction and Pre-Test
Axel Hauschild, MD
12:55pm – 1:20pm
Precision Medicine in Melanoma: Advances in
Knowledge of Biomarkers and Targeted Therapies
Grant McArthur, MD
1:20pm – 1:30pm
Case Presentation
Axel Hauschild, MD
1:30pm – 1:45pm
Post-test and Q&A
Moderated by Axel Hauschild, MD
This continuing medical education activity is provided by Vindico Medical Education
This activity is supported by an educational grant from Novartis.